TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders

Nachrichtenquelle: Business Wire (engl.)
30.09.2020, 23:00  |  139   |   |   

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the results from its Annual Meeting of Stockholders, which took place virtually earlier today. All director nominees were elected to the Board of Directors and Marcum LLP was appointed as the Company’s independent registered public accounting firm for the 2020 fiscal year. A total of 18,076,265 common shares (representing approximately 83% of all issued and outstanding common shares of TFF) were represented at the meeting.

The detailed results of the Annual Meeting were as follows:

1. Election of Directors

All eight (8) nominees for the Board of Directors that were proposed by TFF’s management were elected as a Director of the Company. All the nominated directors were members of the Board of Directors of TFF prior to today’s Meeting. The votes were cast for each nominee as follows:

Nominee

Yes

Withheld

Aaron Fletcher, Ph.D.

11,253,545

28,609

Brian Windsor, Ph.D.

11,253,543

28,611

Stephen C. Rocamboli

11,253,546

28,608

Randy Thurman

11,253,545

28,609

Glenn Mattes

11,253,543

28,611

Robert S. Mills

11,094,669

187,485

Harlan Weisman, M.D.

11,183,280

98,874

Malcolm Fairbairn

11,253,504

28,650

2. Appointment of Auditor

Marcum LLP was appointed as the Company’s independent registered public accounting firm for the 2020 fiscal year. The votes were cast as follows:

Yes

No

Abstain

Seite 1 von 3
TFF Pharmaceuticals Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the results …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
30.09.20